Aegis Biosciences

KEY TEAM MEMBERS

David J. Vachon, Ph.D. - Chief Technology Officer

Dr. Vachon has twenty years of successful experience in the develoment of new products using innovative materials.

David was the Director of Biomaterials and Sensor Technology at MiniMed, Inc. While at MiniMed, Dr. Vachon assumed responsibility for managing an Advanced Technical Program (NIST) toward the development of an optochemical glucose sensor. David previously directed the Department of Materials Technology within St. Jude Medical Inc., Cardiac Rhythm Management Division. Dr. Vachon has more than twenty years of experience with applied research, technology development and technology implementation in the areas of biomaterials and medical devices. Dr. Vachon has eleven awarded patents, more than ten additional patents at various stages of prosecution, and twenty publications.

Dr. Vachon graduated from Framingham State College in 1980 with a BS in Chemistry. In 1984 David earned his Ph.D from the University of New Hampshire (Ph.D. – Organic Chemistry) followed by his Post Doctoral work at UC Santa Barbara finishing in 1986. In 1999 Dr. Vachon received his MBA from California State University . David is on the Board of Directors of Aegis Biosciences, LLC.

Gary E. Wnek, Ph.D. - Partner and Technical Consultant

Dr. Wnek is a founding member of Aegis Biosciences and is well known in the field of polymer science and engineering. His ideas and discoveries in the areas of sulfonated block copolymers have led to the founding of Dais Corporation in 1993 (now Dais-Analytic Corp.), and Aegis Biosciences. He is currently Professor and Chair of the Department of Macromolecular Science and Engineering and Faculty Director of The Institute for Management and Engineering at Case Western Reserve University in Cleveland. He was formerly Founding Chair of the Chemical Engineering Department at Virginia Commonwealth University , Professor and Chair of Chemistry at Rensselaer Polytechnic Institute, and a member of the faculty of the Department of Materials Science and Engineering at MIT.

Dr. Wnek has 130 publications and holds 18 U.S. patents. He graduated from Worcester Polytechnic Institute with a BS in Chemical Engineering (1977) and received a Ph.D. in Polymer Science and Engineering from the University of Massachusetts , Amherst (1980). His research interests include polymers in medicine, microfluidic devices, polymers in fuel cells and batteries, and tools for the acceleration of innovation.

Timothy N. Tangredi - President

Mr. Tangredi has experience in setting strategic direction, creating key alliances, and yielding bottom line results. Earlier in his career, Mr. Tangredi worked for AT&T as a member of the Leadership Continuity Program, where he provided technical marketing, network operations, and project management direction that included providing revenue growth and customer technical support for new AT&T services. After AT&T, Tim owned, operated, and exited an interconnect/electrical business. Tim was appointed President/CEO of Dais Analytic Corporation (DAC) in 1996. In 1999 and 2000, respectively, Mr. Tangredi initiated and executed the strategic purchases of Analytic Power and American Fuel Cell Corporation. Tim was directly responsible for raising the equity investments in DAC to date, including over $5 million in key licensing revenues. In 2000, Tim created two joint ventures for the company – one in Germany, and the other in Korea. Most recently he executed the sale of certain assets to ChevronTexaco. Prior to founding DAC, Tim established and grew several small businesses across a variety of industries. Mr. Tangredi earned his BS from Siena College and his MBA from Rensselaer Polytechnic Institute. He is a founder, and on the Board of Directors of Aegis Biosciences, LLC.




		KEY TEAM MEMBERS David J. Vachon, Ph.D. - Chief Technology Officer Dr. Vachon has twenty years of successful experience in the develoment of new products using innovative materials. David was the Director of Biomaterials and Sensor Technology at MiniMed, Inc. While at MiniMed, Dr. Vachon assumed responsibility for managing an Advanced Technical Program (NIST) toward the development of an optochemical glucose sensor. David previously directed the Department of Materials Technology within St. Jude Medical Inc., Cardiac Rhythm Management Division. Dr. Vachon has more than twenty years of experience with applied research, technology development and technology implementation in the areas of biomaterials and medical devices. Dr. Vachon has eleven awarded patents, more than ten additional patents at various stages of prosecution, and twenty publications. Dr. Vachon graduated from Framingham State College in 1980 with a BS in Chemistry. In 1984 David earned his Ph.D from the University of New Hampshire (Ph.D. – Organic Chemistry) followed by his Post Doctoral work at UC Santa Barbara finishing in 1986. In 1999 Dr. Vachon received his MBA from California State University . David is on the Board of Directors of Aegis Biosciences, LLC. Gary E. Wnek, Ph.D. - Partner and Technical Consultant Dr. Wnek is a founding member of Aegis Biosciences and is well known in the field of polymer science and engineering. His ideas and discoveries in the areas of sulfonated block copolymers have led to the founding of Dais Corporation in 1993 (now Dais-Analytic Corp.), and Aegis Biosciences. He is currently Professor and Chair of the Department of Macromolecular Science and Engineering and Faculty Director of The Institute for Management and Engineering at Case Western Reserve University in Cleveland. He was formerly Founding Chair of the Chemical Engineering Department at Virginia Commonwealth University , Professor and Chair of Chemistry at Rensselaer Polytechnic Institute, and a member of the faculty of the Department of Materials Science and Engineering at MIT. Dr. Wnek has 130 publications and holds 18 U.S. patents. He graduated from Worcester Polytechnic Institute with a BS in Chemical Engineering (1977) and received a Ph.D. in Polymer Science and Engineering from the University of Massachusetts , Amherst (1980). His research interests include polymers in medicine, microfluidic devices, polymers in fuel cells and batteries, and tools for the acceleration of innovation. *Timothy N. Tangredi - President* Mr. Tangredi has experience in setting strategic direction, creating key alliances, and yielding bottom line results. Earlier in his career, Mr. Tangredi worked for AT&T as a member of the Leadership Continuity Program, where he provided technical marketing, network operations, and project management direction that included providing revenue growth and customer technical support for new AT&T services. After AT&T, Tim owned, operated, and exited an interconnect/electrical business. Tim was appointed President/CEO of Dais Analytic Corporation (DAC) in 1996. In 1999 and 2000, respectively, Mr. Tangredi initiated and executed the strategic purchases of Analytic Power and American Fuel Cell Corporation. Tim was directly responsible for raising the equity investments in DAC to date, including over $5 million in key licensing revenues. In 2000, Tim created two joint ventures for the company – one in Germany, and the other in Korea. Most recently he executed the sale of certain assets to ChevronTexaco. Prior to founding DAC, Tim established and grew several small businesses across a variety of industries. Mr. Tangredi earned his BS from Siena College and his MBA from Rensselaer Polytechnic Institute. He is a founder, and on the Board of Directors of Aegis Biosciences, LLC.

		OVERVIEW \| TECHNOLOGY \| STRATEGIC ALLIANCES \| NEWS \| CONTACT US \| SITE MAP \| HOME
		COPYRIGHT © 2005 - AEGIS BIOSCIENCES LLC